Does NEVIRAPINE Cause Hepatocellular carcinoma? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hepatocellular carcinoma have been filed in association with NEVIRAPINE (Nevirapine). This represents 0.1% of all adverse event reports for NEVIRAPINE.
5
Reports of Hepatocellular carcinoma with NEVIRAPINE
0.1%
of all NEVIRAPINE reports
4
Deaths
1
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From NEVIRAPINE?
Of the 5 reports, 4 (80.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEVIRAPINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does NEVIRAPINE Cause?
Foetal exposure during pregnancy (1,337)
Drug resistance (862)
Virologic failure (813)
Viral mutation identified (518)
Death (514)
Exposure during pregnancy (462)
Pathogen resistance (356)
Treatment failure (340)
Lipodystrophy acquired (288)
Maternal exposure during pregnancy (283)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which NEVIRAPINE Alternatives Have Lower Hepatocellular carcinoma Risk?
NEVIRAPINE vs NEXAVAR
NEVIRAPINE vs NEXIUM
NEVIRAPINE vs NEXPLANON
NEVIRAPINE vs NIACIN
NEVIRAPINE vs NIACINAMIDE